Top 20 Roivant Sciences investors
The most complete profiles first. Showing 20 of 20.
Joshua KennedyVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Verified email available
Stephanie A. SirotaVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsEnterprise SoftwareInvestment ManagementPortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Verified email available
Naveen Yalamanchi
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Contact details available
Piratip Pratumsuwan
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more
Contact details available
Roderick Wong
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more
Contact details available
Sabera Loughran
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Contact details available
Tony Nguyen
Hedge Fund, Venture Capital, Investor · United States
Series BAdvertisingHealth CareGeneticsInvestment ManagementPortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Contact details available
Brian AxeVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more
Contact details available
Christina SmithVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more
Verified email available
John BradleyVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more
Verified email available
Michael SorensenVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more
Verified email available
Patrick JordanVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more
Verified email available
Ryan WootenVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more
Verified email available
Anthony DiNoto
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more
Contact details available
Devin Rosenthal, PhD, MBA
Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more
Contact details available
Guy Petrelli
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more
Contact details available
Jeff Edwards
Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more
Contact details available
Jonathan Tunnicliffe
Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more
Contact details available
Robert Hester, CPA
Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more
Contact details available
Vern Davenport
Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Mileutis13
- PreCision Dermatology13
- InformedDNA13
- Arvelle Therapeutics13
- BioCritica13
- Clinical Ink13
- Mesoblast13
- ITeos Therapeutics7
- Orchestra BioMed7
- NiKang Therapeutics7
- Avidity Biosciences7
Frequently asked questions
How many Roivant Sciences investors are on Angel Roster?
Angel Roster lists 20 Roivant Sciences investors. 7 of them (35%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (20) and Hedge Funds (7). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Roivant Sciences investors invest in?
Among those that list a stage, the most common are Series B (7).
Where are Roivant Sciences investors based?
Most are based in the United States (20).
Which companies have Roivant Sciences investors backed?
The most-backed portfolio companies among them are Mileutis (13), PreCision Dermatology (13), InformedDNA (13), Arvelle Therapeutics (13) and BioCritica (13).
How do I contact Roivant Sciences investors?
Create a free Angel Roster account to search and filter all 20, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.